Questions & explanations
1. Compare the prevention strategies for congenital toxoplasmosis and congenital Chagas disease.
For congenital toxoplasmosis, prevention focuses on avoiding infection during pregnancy: not eating raw or undercooked meat, washing fruits and vegetables, and avoiding cat litter. For congenital Chagas, prevention involves screening pregnant women in endemic areas and treating them if infected. In some countries, babies are tested at birth and treated early. There is no vaccine for either disease. Toxoplasmosis prevention is about behavior change, while Chagas prevention relies on vector control and screening. Both require health education for pregnant women. Treatment during pregnancy can reduce transmission for toxoplasmosis but is less effective for Chagas.
2. How is leishmaniasis transmitted and what are its main forms?
Leishmaniasis is caused by Leishmania parasites, spread by the bite of infected sand flies. There are three main forms: cutaneous (skin), mucocutaneous (skin and mucous membranes), and visceral (internal organs). Cutaneous leishmaniasis causes skin sores that heal slowly, leaving scars. Mucocutaneous affects the nose and mouth, causing tissue destruction. Visceral leishmaniasis, also called kala-azar, affects the spleen, liver, and bone marrow, causing fever, weight loss, and anemia, and can be fatal if untreated. Diagnosis is by finding the parasite in tissue samples or blood tests. Treatment depends on the form and includes antimony drugs or amphotericin B.
3. What is the main prevention strategy for onchocerciasis?
The main prevention is community-wide treatment with ivermectin, given once or twice a year. Ivermectin kills the microfilariae in the skin and eyes, reducing symptoms and preventing transmission to others. It does not kill adult worms, so treatment must continue for many years until the adult worms die naturally. Vector control by spraying insecticides against black flies also helps. In some areas, eliminating the black fly breeding sites reduces the disease. Personal protection like insect repellent and netting is less effective because black flies bite during the day. The goal is to eliminate river blindness as a public health problem.
4. How does being a traveler increase the risk of getting a parasitic infection?
Travelers visit areas where parasites are common and may not have immunity. They can get infected by mosquito bites (malaria, dengue), contaminated food or water (Giardia, amoebas), or walking barefoot on soil (hookworm). For example, a tourist swimming in Lake Malawi can get schistosomiasis. Travelers often do not take preventive medicine or use bed nets. They may also eat street food that is not properly cooked. After returning home, they might not be diagnosed quickly because doctors in their home country may not think of parasitic diseases. So travelers should take precautions like using repellents and drinking bottled water.
5. What is Integrated Vector Management (IVM)?
Integrated Vector Management (IVM) is a way to control disease-carrying vectors (like mosquitoes and ticks) using a combination of different methods. Instead of relying on just one method, like spraying insecticides, IVM uses several approaches together. These include environmental management (removing breeding sites), biological control (using natural enemies), chemical control (insecticides), and personal protection (bed nets, repellents). IVM also involves monitoring the vectors and making decisions based on local conditions. The goal is to reduce vector numbers and disease transmission in a sustainable, cost-effective way.
6. How does the strategy for eliminating lymphatic filariasis differ from that for malaria?
For lymphatic filariasis, the main strategy is mass drug administration (MDA) to kill the parasites in humans. The drugs are given yearly for 4-6 years to break transmission. For malaria, MDA is also used but less often; the main strategies are vector control (bed nets, spraying) and prompt treatment of cases. Malaria also has a vaccine for some types. Lymphatic filariasis is harder to diagnose because symptoms appear years after infection. Both require high coverage and monitoring. However, lymphatic filariasis elimination is considered feasible because the parasite does not multiply in mosquitoes, and drugs are effective.
7. How is Chagas disease diagnosed in the chronic phase?
In the chronic phase, the parasite is hard to find in blood, so diagnosis relies on serology tests that detect antibodies against T. cruzi. Two different serology tests are usually done to confirm. PCR can also be used but is less sensitive in chronic cases. If heart or digestive problems are present, tests like electrocardiogram (ECG) or X-rays help assess damage. Xenodiagnosis is rarely used now. Early diagnosis in the acute phase is better, but many people are diagnosed years later when symptoms appear. Treatment in chronic phase is less effective, but antiparasitic drugs may still be given to slow disease progression.
8. Why is congenital transmission of parasitic diseases a public health concern?
Congenital transmission can cause lifelong health problems in children, such as blindness, brain damage, or heart disease. These children may need special care and treatment for many years. Also, infected babies can grow up and transmit the parasite to their own children, continuing the cycle. In areas where these parasites are common, many pregnant women are at risk. Public health programs can prevent congenital infections by educating women and screening them during pregnancy. Treating infected mothers and babies can reduce the number of cases. This is especially important for diseases like toxoplasmosis and Chagas.
9. Compare immunosuppression by Leishmania and by parasitic worms.
Both Leishmania and parasitic worms suppress the immune system, but they use different methods. Leishmania lives inside macrophages and directly stops them from killing the parasite. It also changes cytokine signals to reduce inflammation. Parasitic worms, like Heligmosomoides, often live in the gut and induce regulatory T cells, which suppress other immune cells. Worms also secrete molecules that mimic host regulatory proteins. Both strategies result in a weaker immune response that allows the parasite to survive. However, Leishmania acts more locally inside cells, while worms affect the broader immune environment.
10. What is pyrimethamine and how is it used against Toxoplasma gondii?
Pyrimethamine is an antiparasitic drug that inhibits dihydrofolate reductase, an enzyme the parasite needs to make DNA. It is used to treat toxoplasmosis, often in combination with sulfadiazine, which blocks a different step in the same pathway. This combination is the standard treatment for active Toxoplasma infections, especially in people with weak immune systems, like those with HIV. Pyrimethamine is given orally, and treatment usually lasts several weeks. Side effects include bone marrow suppression, so patients take folinic acid to protect their own cells. It is also used for malaria prevention in some areas.
11. How do travel and migration affect the regional epidemiology of parasitic diseases?
Travel and migration can bring parasites from one region to another. For example, a person infected with malaria in Africa can travel to Europe and get bitten by a mosquito, starting local transmission if the climate allows. Migrant workers from Southeast Asia can bring drug-resistant malaria to new areas. Tourists can get infected with schistosomiasis by swimming in lakes in Africa and then return home, but they usually do not spread it because the snails are not present. However, some parasites like Giardia can spread through contaminated food anywhere. So regions must monitor imported cases to prevent outbreaks.
12. What does it mean to eliminate a parasitic disease?
Elimination means stopping transmission of a disease in a specific area, so no new cases appear. For example, malaria elimination in a country means no one gets malaria from local mosquitoes. Eradication is the complete removal of the parasite worldwide, like smallpox. For parasites, elimination is often the goal first. Strategies include treating all infected people, controlling vectors like mosquitoes, and preventing infection. Challenges include the parasite hiding in the body or in animals. For example, Guinea worm is close to eradication because it only infects humans and can be prevented with clean water.